COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT00130507
Brief Title: Benefit of Adding Trastuzumab to Second Line Chemotherapy in Breast Cancer Patients Previously Treated With Trastuzumab

First Submitted : August 12, 2005
First Submitted that Met QC Criteria : August 12, 2005
First Posted : August 15, 2005 (Estimate)

Last Update Submitted that Met QC Criteria : February 25, 2019
Last Update Posted : February 26, 2019